By Eric Volkman
The world is buckling under the weight of the SARS-CoV-2 coronavirus and the disease resulting from it, COVID-19. Despite occasional recoveries amid bouts of optimism, stocks have headed steeply downward. It’s no different for marijuana companies.
The withering effect of the coronavirus pandemic was felt acutely in the sector last week, but it wasn’t the only factor affecting the decline. Here are two other developments during the period worth noting.